Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

Generic: The gross margin story remains strong - ABG

Generic Sweden

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* Sales up 3% y-o-y, held back by soft volumes and tough comps
* We keep sales flat, and slightly raise opex
* Trading at 9-8x on '26e-'27e EV/EBITA, below its historical median


Recruiting and consulting costs weighing on EBIT

Generic reported an in-line Q4, with sales of SEK 49m, up 3% y-o-y, affected by softer volumes and tough comps. The gross margin came in at 44%, up from last year, indicating that SaaS continues to grow. Adj. EBIT decreased 4% y-o-y, primarily due to recruiting and consulting costs. It is also worth noting that Q4'24 was exceptionally strong. Looking at the full year, Generic grew adj. EBIT by 22% y-o-y. The DPS was proposed at SEK 1.75 (1.60 last year), and we note it has increased over the last 5 years, signalling earnings stability.


We raise opex by ~3%, but keep our view on scaling potential

We expect more top-line growth in 2026, as volumes should pick up, and as Generic continues to penetrate more customer groups. We raise operating costs slightly for '26e-'27e but keep our view of it reaching 22-23% EBIT margins, as we see potential for further scaling.


Volumes should pick up in 2026

Generic is currently trading at 9-8x '26e-'27e EV/EBITA, which is ~35% below its historical median. The messaging market has been impacted by pricing sensitivity, as customers in, e.g., logistics, have cut costs. However, churn remains low, and we believe volumes should pick up in 2026. DOCS continues to grow within municipalities, and Generic is starting to reposition the product as a document transfer product. This targets other customer segments, such as private healthcare companies and Swedish regions, and over time, this should scale and increase margins.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.